{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:00:10Z","timestamp":1791576010998,"version":"4.3.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/pas.0000000000000554","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T05:48:17Z","timestamp":1446875297000},"page":"544-553","source":"Crossref","is-referenced-by-count":226,"title":["SWI\/SNF Complex\u2013deficient Undifferentiated\/Rhabdoid Carcinomas of the Gastrointestinal Tract"],"prefix":"10.1097","volume":"40","author":[{"given":"Abbas","family":"Agaimy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"M\u00e4rkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Lichtmannegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210131","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1073\/pnas.91.8.2905","article-title":"Five SWISNF gene products are components of a large multisubunit complex required for transcriptional enhancement.","volume":"91","author":"Peterson","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R2-16-20210131","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.c.31410","article-title":"SWISNF chromatin remodeling complexes and cancer.","volume":"166C","author":"Biegel","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R3-16-20210131","doi-asserted-by":"crossref","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWISNF mutations, ubiquitous in human cancers.","volume":"8","author":"Shain","year":"2013","journal-title":"PLoS One"},{"key":"R4-16-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1158\/1078-0432.CCR-13-0280","article-title":"Molecular pathways: SWISNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R5-16-20210131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":". SWISNF chromatin remodeling and human malignancies.","volume":"10","author":"Masliah-Planchon","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"R6-16-20210131","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajhg.2012.02.007","article-title":". Haploinsufficiency of ARID1B, a member of the SWISNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability.","volume":"90","author":"Hoyer","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R7-16-20210131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajmg.c.31415","article-title":"Coffin-Siris syndrome and related disorders involving components of the BAF (mSWISNF) complex: historical review and recent advances using next generation sequencing.","volume":"166C","author":"Kosho","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R8-16-20210131","first-page":"3461","article-title":". Alterations of the hSNF5INI1 gene in central nervous system atypical teratoidrhabdoid tumors and renal and extrarenal rhabdoid tumors.","volume":"8","author":"Biegel","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R9-16-20210131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAP.0b013e3180ca8b08","article-title":"Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.","volume":"14","author":"Judkins","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"R10-16-20210131","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics.","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R11-16-20210131","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","article-title":"The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.","volume":"21","author":"Agaimy","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"R12-16-20210131","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases.","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R13-16-20210131","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":". Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat Genet"},{"key":"R14-16-20210131","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":". Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"R15-16-20210131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWISNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma.","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"R16-16-20210131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1746-1596-8-31","article-title":". Right-sided rhabdoid colorectal tumors might be related to the serrated pathway.","volume":"8","author":"Pancione","year":"2013","journal-title":"Diagn Pathol"},{"key":"R17-16-20210131","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/PAS.0000000000000173","article-title":". SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.","volume":"38","author":"Agaimy","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R18-16-20210131","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PDM.0b013e3181db67af","article-title":". A multicenter study to validate the reproducibility of MSI testing with a panel of 5 quasimonomorphic mononucleotide repeats.","volume":"19","author":"Nardon","year":"2010","journal-title":"Diagn Mol Pathol"},{"key":"R19-16-20210131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.2014.100","article-title":". Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.","volume":"28","author":"Agaimy","year":"2015","journal-title":"Mod Pathol"},{"key":"R20-16-20210131","first-page":"101","article-title":"Unusual carcinomas of the pancreas.","volume":"58","author":"Sommers","year":"1954","journal-title":"AMA Arch Pathol"},{"key":"R21-16-20210131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2559.1992.tb00947.x","article-title":"Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern.","volume":"20","author":"Bittesini","year":"1992","journal-title":"Histopathology"},{"key":"R22-16-20210131","first-page":"233","article-title":"Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion.","volume":"12","author":"Wick","year":"1995","journal-title":"Semin Diagn Pathol"},{"key":"R24-16-20210131","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/modpathol.3800375","article-title":". INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.","volume":"18","author":"Perry","year":"2005","journal-title":"Mod Pathol"},{"key":"R25-16-20210131","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.06.001","article-title":". SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.","volume":"19","author":"Agaimy","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"R26-16-20210131","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":". SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R27-16-20210131","first-page":"5517","article-title":". Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.","volume":"34","author":"Vanacker","year":"2014","journal-title":"Anticancer Res"},{"key":"R28-16-20210131","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1128\/MCB.01372-13","article-title":". Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.","volume":"34","author":"Wilson","year":"2014","journal-title":"Mol Cell Biol"},{"key":"R29-16-20210131","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.humpath.2014.06.027","article-title":". Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWISNF complex members to pathogenesis.","volume":"45","author":"Li","year":"2014","journal-title":"Hum Pathol"},{"key":"R30-16-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12632","article-title":". Frequent co-inactivation of the SWISNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.","volume":"67","author":"Rao","year":"2015","journal-title":"Histopathology"},{"key":"R31-16-20210131","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.28705","article-title":". Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.","volume":"135","author":"Cajuso","year":"2014","journal-title":"Int J Cancer"},{"key":"R32-16-20210131","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.humpath.2014.08.007","article-title":". Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.","volume":"45","author":"Ye","year":"2014","journal-title":"Hum Pathol"},{"key":"R33-16-20210131","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.humpath.2014.04.009","article-title":". Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.","volume":"45","author":"Chou","year":"2014","journal-title":"Hum Pathol"},{"key":"R34-16-20210131","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1600-0463.2012.02930.x","article-title":". Loss of ARID1A expression is uncommon in gastric, colorectal, and prostate cancers.","volume":"120","author":"Kim","year":"2012","journal-title":"APMIS"},{"key":"R35-16-20210131","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fonc.2014.00372","article-title":". Beyond mutations: additional mechanisms and implications of SWISNF complex inactivation.","volume":"4","author":"Marquez","year":"2015","journal-title":"Front Oncol"},{"key":"R36-16-20210131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.humpath.2014.11.021","article-title":". Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.","volume":"46","author":"Singhi","year":"2015","journal-title":"Hum Pathol"},{"key":"R37-16-20210131","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-14-0849","article-title":". ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors.","volume":"5","author":"Shen","year":"2015","journal-title":"Cancer Discov"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:45:58Z","timestamp":1620953158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201604000-00016"}},"subtitle":["A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2"],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000554","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}